[Federal Register Volume 68, Number 197 (Friday, October 10, 2003)]
[Notices]
[Page 58692]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-25778]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Notice of Meeting; Interagency Autism Coordinating Committee

    The National Institutes of Health (NIH) hereby announces a meeting 
of the Interagency Autism Coordinating Committee (IACC) to be held on 
November 21, 2003, on the NIH campus in Bethesda, Maryland.
    The Children's Health Act of 2000 (Pub. L. 106-310), Title I, 
section 104, mandated the establishment of an Interagency Autism 
Coordinating Committee (IACC) to coordinate autism research and other 
efforts within the Department of Health and Human Services (DHHS). In 
April 2001, Secretary Tommy Thompson delegated the authority to 
establish the IACC to the National Institutes of Health (NIH). The 
National Institute of Mental Health (NIMH) at the NIH has been 
designated the lead for this activity.
    The IACC meeting will be open to the public, with attendance 
limited to space available. Individuals who plan to attend and need 
special assistance, such as sign language interpretation or other 
reasonable accommodations, should notify the contact person listed 
below in advance of the meeting.

    Name of Committee: Interagency Autism Coordinating Committee.
    Date: November 21, 2003.
    Time: 10:30 a.m.-3:30 p.m.
    Agenda: Discussion of autism activities across Federal agencies.
    Place: National Institutes of Health, 9000 Rockville Pike, 
Building 31, Conference Room 10 (6th floor), Bethesda, Maryland 
20892.
    Contact Person: Ann Wagner, Ph.D., Division of Services and 
Intervention Research, National Institute of Mental Health, NIH, 
6001 Executive Boulevard, Room 7142, MSC 9633, Bethesda, Maryland 
20892, E-mail: [email protected], Phone: (301) 443-4283.

    Any member of the public interested in presenting oral comments to 
the committee may notify the contact person listed on this notice at 
least 5 days in advance of the meeting. Interested individuals and 
representatives of organizations may submit a letter of intent, a brief 
description of the organization represented, and a short description of 
the oral presentation. Presentations may be limited to 5 minutes; both 
printed and electronic copies are requested for the record. In 
addition, any interested person may file written comments with the 
committee by forwarding his/her statement to the contact person listed 
on this notice. The statement should include the name, address, 
telephone number and, when applicable, the business or professional 
affiliation of the interested person.
    Information about the meeting and on-line registration forms are 
also available on-line on the NIMH homepage at http://www.nimh.nih.gov/autismiacc/index.cfm.

    Dated: October 3, 2003.
Raynard Kington,
Deputy Director, National Institutes of Health.
[FR Doc. 03-25778 Filed 10-9-03; 8:45 am]
BILLING CODE 4140-01-P